Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entrectinib in advanced or metastatic solid tumors with NTRK1/2/3, ROS1, or ALK rearrangements
CTR20191623Phase 2Active
- Sponsor
- Roche
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entrectinib in Nonhematologic neoplasms, sponsored by Roche. Started Apr 2020; status: active.
02
Drugs
entrectinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20191623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191623.